Procure-to-Pay (P2P) is the operational backbone of procurement in biotech and pharma. It connects lab purchasing activity to financial controls, compliance requirements, and supplier management.
In research-driven organizations, P2P is not just an accounting workflow. It directly affects research timelines, audit readiness, and cost visibility.
This guide explains how the P2P lifecycle works in life sciences, where bottlenecks occur, and how automation strengthens performance.
For a broader strategic view of procurement in biotech and pharma, see our guide to life sciences procurement strategy.
💡
What is procure-to-pay (P2P)?
Procure-to-Pay (P2P) is the end-to-end workflow that manages purchasing and payment processes. It begins when a purchasing need is identified and ends when a supplier is paid.
In life sciences organizations, P2P governs:
- Laboratory supply purchasing
- Lab equipment procurement
- Supplier onboarding
- Invoice reconciliation
- Financial posting and reporting
The goal of P2P is control, accuracy, and traceability across the entire purchasing lifecycle.
The P2P lifecycle in biotech and pharma
The core stages of P2P include:
- Need identification
A purchasing request is created for lab supplies, reagents, equipment, or services. - Supplier selection
Approved suppliers are evaluated based on price, contract terms, availability, and compliance requirements. - Purchase order creation
A formal PO is issued and routed through internal approval workflows. - Receipt of goods or services
Items are received, inspected, and documented. - Invoice processing
Invoices are matched against purchase orders and receiving documentation. - Payment
Approved invoices are processed according to agreed terms.
In regulated environments, each stage must be auditable and aligned with internal controls and current Good Manufacturing Practice (cGMP) requirements.
Why P2P is complex in life sciences
While the workflow appears linear, research environments introduce additional variables:
Longtail scientific purchasing
R&D teams frequently require niche or low-volume items not covered under standard contracts.
PunchOut catalog sprawl
Organizations may manage dozens or hundreds of supplier PunchOut catalogs, creating fragmented purchasing experiences.
Regulatory oversight
GxP and grant-funded research require documentation and approval traceability.
Vendor exceptions and backorders
Research timelines are sensitive to delays. Substitutions must be carefully evaluated to preserve experimental integrity.
These complexities make full automation more challenging in life sciences than in traditional corporate procurement.
Common P2P bottlenecks in R&D organizations
Many biotech and pharma organizations experience recurring operational bottlenecks:
- Manual data entry and invoice matching
- Approval routing delays
- Limited real-time spend visibility
- Disconnected supplier systems
- Inconsistent receiving documentation
- Fragmented communication between R&D and finance
When these inefficiencies compound, procurement becomes reactive rather than strategic.
How ERP systems fit into P2P workflows
Enterprise Resource Planning (ERP) systems provide financial governance, but they do not always solve sourcing fragmentation. These systems typically manage financial posting, general ledger controls, and payment processing.
However, sourcing, supplier comparison, and real-time product availability often occur outside the ERP layer.
Effective P2P automation requires coordination between sourcing systems and ERP infrastructure.
The role of PunchOut in P2P automation
PunchOut catalogs allow buyers to access supplier product catalogs directly through procurement systems.
While PunchOut enables contract compliance and structured purchasing, managing multiple lab supply PunchOut catalogs can create:
- Interface inconsistency
- Reduced price comparison visibility
- Increased error risk
- Administrative overhead
Consolidating PunchOut access improves usability and strengthens governance.
Best practices for optimizing P2P in life sciences
Organizations seeking stronger P2P performance typically focus on:
Automating invoice matching
3-way matching reduces reconciliation errors and accelerates payment cycles.
Standardizing approval workflows
Clear thresholds prevent approval bottlenecks and improve audit readiness.
Centralizing supplier access
Reducing supplier sprawl strengthens visibility and contract compliance.
Improving spend reporting
Project-level spend visibility supports forecasting and cost control.
Aligning procurement and finance teams
Cross-functional coordination reduces delays and strengthens internal controls.
How ZAGENO supports P2P automation in life sciences
ZAGENO integrates with leading P2P and ERP platforms to strengthen workflow coordination across sourcing and finance.
Capabilities include:
- Consolidated PunchOut access
- Automated 3-way matching
- Configurable approval routing
- Real-time order tracking
- ERP integrations including Coupa, SAP Ariba, Jaggaer, NetSuite, and others
By connecting sourcing workflows to financial systems, P2P processes become more consistent and auditable.
Case study: P2P automation at a biotech organization
A 54-person biotech company operating with manual lab supply ordering sought to modernize its P2P workflow.
After integrating a centralized sourcing platform with its ERP system, the organization:
- Automated vendor setup
- Consolidated invoices
- Reduced administrative workload
- Increased on-time delivery performance
Results:
- $326,575 in labor savings
- 3,585 hours saved
- 91% on-time order delivery
- Improved spend visibility and approval flow optimization
Strengthening P2P for research continuity
In life sciences, procurement workflows directly influence research speed. A structured, automated P2P system improves:
- Financial accuracy
- Audit readiness
- Supplier coordination
- Administrative efficiency
- Research continuity
When sourcing and finance operate in alignment, procurement becomes a strategic enabler of discovery.